Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Enhancing immune response can improve cancer treatment effectiveness.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Deucravacitinib helped a man regrow hair significantly.

AS101 reduces hair loss from chemotherapy.

Advanced imaging methods have improved understanding of cancer cell interactions and treatment strategies.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Pulsed electric field treatment may help the immune system fight liver tumors.

Bee venom can help stem cells promote hair growth.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Rituximab can cause skin issues, but baricitinib may help improve them.

The treatment was ineffective in humans.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Bimatoprost effectively improves eyelashes in chemotherapy patients.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Bee venom is used in cosmetics for skin issues but may cause allergic reactions.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.